glp 1 approved for type 1 diabetes What to Make of the GLP-1 Coverage and Cost Landscape GLP-1s for Type 1 Diabetes?
Description
Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary

Treatment options for patients with type 2 diabetes mellitus have increased with the addition of three new drug classes

This systematic review and meta-analysis aims to update the evidence on the impact of GLP-1 RAs on EGD outcomes, evaluate the effect of concurrent colonoscopy (CLN) on GRC, and assess the influence of different GLP-1 RA agents on GRC

And explains why many plans are dropping coverage for an effective (and cost-effective) class of drugs

It seems like Eli Lilly is poised to dominate once Retatrutide gets approved (and chinese "research chemical" factories will win either way.) So, does Eli Lilly = ASU frat leader?

While GLP-1 drugs remain wildly popular and are a highly lucrative sector, data analytics firm GlobalData contends manufacturing and cost will remain overhangs on the obesity market.
